Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial
Resource Type
Article
Authors
Ragni, Margaret V ; Rothenberger, Scott D ; Feldman, Robert ; Nance, Danielle ; Leavitt, Andrew D ; Malec, Lynn ; Kulkarni, Roshni ; Sidonio, Robert, Jr ; Kraut, Eric ; Lasky, Joseph ; Pruthi, Rajiv ; Angelini, Dana ; Philipp, Claire ; Hwang, Nina ; Wheeler, Allison P ; Seaman, Craig ; Machin, Nicoletta ; Xavier, Frederico ; Meyer, Michael ; Bellissimo, Daniel ; Humphreys, Gregory ; Smith, Kenneth J ; Merricks, Elizabeth P ; Nichols, Timothy C ; Ivanco, Dana ; Vehec, Deborah ; Koerbel, Glory ; Althouse, Andrew D
Source
In The Lancet Haematology August 2023 10(8):e612-e623
Subject
Primary Research Articles
Language
ISSN
2352-3026